Who Owns Siemens Healthineers?

• Parent Company: Siemens AG
• Ownership Type: Acquired
• Company Type: Publicly Traded
• Stock Ticker: Frankfurt Stock Exchange: SIE

• Founded: 2018
• Founders: Siemens AG (spin-off)

• Founded: 1847
• Headquarters: Munich, Germany
• Company Type: Publicly Traded
• Stock: Frankfurt Stock Exchange: SIE
• Revenue: approximately €78.5 billion (FY2025, year ended September 2025)
• Employees: Approximately 285,000

Visit Siemens AG website

• Headquarters: Erlangen, Germany
• Manufacturing / Operations: Germany, United States, Europe, Asia

Siemens Healthineers operates under a comprehensive sustainability framework focused on three pillars: Healthcare Access, Resource Preservation, and Diverse and Engaged Healthineers. The company has established ambitious environmental and social goals while maintaining ethical business practices in the medical technology sector.

Healthcare Access Initiatives: Siemens Healthineers demonstrates commitment to healthcare access through global partnerships and programs. In Colombia, nearly 200,000 women have benefited from breast cancer initiatives, with 73% of women with suspected breast cancer able to access biopsies as of October 2024. In 2025, new breast cancer programs were launched in Kumasi, Ghana, and Tbilisi, Georgia, expanding access to critical diagnostic services in underserved communities.

Resource Preservation: The company focuses on environmental sustainability through resource efficiency and climate action initiatives. Siemens Healthineers has achieved half of its sustainability targets ahead of schedule by fiscal 2024, demonstrating effective environmental management. The company's sustainability strategy includes reducing environmental impact across its operations and supply chain.

Diversity and Inclusion: Siemens Healthineers prioritizes gender equality and workforce diversity. The company aims to increase the proportion of women in senior management positions to 26% by fiscal year 2025. As of September 30, 2023, the company had already achieved 25% women in senior management positions, demonstrating progress toward gender equality goals.

Environmental Compliance: Beginning in fiscal year 2025, Siemens Healthineers' sustainability reporting complies with the European Union's Corporate Sustainability Reporting Directive (CSRD) and European Sustainability Reporting Standards (ESRS). This compliance reflects the company's commitment to transparent environmental and social reporting.

Ethical Business Practices: As a medical technology company, Siemens Healthineers maintains strict ethical standards in product development, manufacturing, and customer relationships. The company operates under comprehensive compliance programs ensuring adherence to medical device regulations and ethical business conduct across global markets.

Employee Engagement: The company supports employee-led sustainability initiatives and volunteering programs. These efforts include community engagement projects and employee-driven environmental and social responsibility activities that contribute to broader societal impact beyond core business operations.

Innovation for Sustainability: Siemens Healthineers integrates sustainability considerations into product development, creating medical technologies that improve healthcare efficiency while reducing environmental footprint. The company's innovation strategy includes developing more energy-efficient medical devices and sustainable healthcare solutions.

Siemens Healthineers has received significant recognition for excellence in medical technology innovation, sustainability leadership, and corporate performance. These awards reflect the company's position as a global leader in diagnostic imaging, laboratory diagnostics, and healthcare IT solutions.

Frost & Sullivan 2025 Company of the Year Award: Siemens Healthineers received the prestigious Frost & Sullivan 2025 North America Company of the Year Award for Excellence in Advanced Visualization Applications. The award recognized the company's exceptional performance across two core dimensions: visionary innovation and customer impact. Frost & Sullivan's rigorous benchmarking process highlighted Siemens Healthineers' compelling ability to align long-term innovation with customer needs.

Berkeley Haas Best Case Award 2025: Siemens Healthineers received the Berkeley Haas Best Case Award for its digital transformation journey. The case study documented the company's successful digital transformation in medical technology, highlighting innovative approaches to integrating digital solutions with traditional medical equipment and services.

Siemens Inventor of the Year Recognition: While the award is presented by parent company Siemens, Siemens Healthineers employees have been recognized among Siemens' leading inventors. In 2024, thirteen "Inventors of the Year" were awarded, with artificial intelligence playing a role in over half of the winning solutions, demonstrating the company's strength in healthcare AI innovation.

Sustainability Leadership Recognition: Siemens Healthineers has been acknowledged for its sustainability achievements, particularly for achieving half of its sustainability targets ahead of schedule by fiscal 2024. The company's comprehensive sustainability reporting and compliance with CSRD and ESRS standards have been recognized as industry-leading practices.

Healthcare Technology Innovation: The company has received recognition for developing innovative medical technologies that improve diagnostic accuracy, enhance patient care, and increase healthcare system efficiency. Awards from medical technology organizations have highlighted Siemens Healthineers' contributions to advancing healthcare through technological innovation.

Global Market Leadership: Industry analysts and market research firms have consistently recognized Siemens Healthineers as a market leader in diagnostic imaging, laboratory diagnostics, and healthcare IT solutions. The company's global presence and comprehensive product portfolio have been acknowledged as competitive advantages in the medical technology sector.

Customer Satisfaction Awards: Healthcare providers and medical institutions have recognized Siemens Healthineers for product quality, customer service, and technical support excellence. These awards reflect the company's commitment to customer success and partnership in healthcare delivery.

Digital Health Innovation: Siemens Healthineers has received recognition for integrating digital technologies with medical equipment, creating smart healthcare solutions that improve diagnostic capabilities and operational efficiency for healthcare providers.

Siemens Healthineers has faced some product recalls and regulatory challenges typical of the medical technology industry, particularly concerning its MRI systems. The company maintains strict quality control and safety standards, though like all medical device manufacturers, it occasionally faces issues requiring product corrections and recalls.

MRI System Class 1 Recall (2025): In October 2025, the U.S. Food and Drug Administration announced a Class 1 recall affecting several types of Siemens Healthineers MRI systems. The recall impacted nine different scanners from the Magnetom series of magnetic resonance imaging systems. The FDA identified this as the most serious type of recall, indicating that continued use of the devices without correction could cause serious injury or death.

Magnetom MRI Systems Recall: Siemens Healthineers issued a recall notice for nine of its Magnetom MRI systems worldwide. The recall was prompted by an error message reading "Magnet Supervision: The average heater power is above the alarm threshold. Please contact Siemens Healthineers Service." The company notified consignees via letter on August 28, 2025, and instructed customers not to reboot the system if they encountered this issue, but to contact local Siemens Customer Service Organization.

3 Tesla MRI Systems Correction: The FDA issued an alert regarding Siemens Healthineers' correction for 3 Tesla MRI systems. The safety warning addressed potential issues with the magnet supervision system that could lead to overheating if not properly addressed. The company conducted inspections of affected units to address the issue and ensure system safety.

Regulatory Compliance Challenges: As a global medical technology company, Siemens Healthineers faces ongoing regulatory compliance challenges across different markets. The company must maintain compliance with varying medical device regulations, quality standards, and reporting requirements across the United States, Europe, Asia, and other international markets.

Product Quality Assurance: Siemens Healthineers maintains comprehensive quality assurance programs across its manufacturing operations. The company implements rigorous testing and validation processes for medical devices, though occasional quality issues can arise in complex medical equipment manufacturing.

Supply Chain Complexity: The company's global supply chain for medical technology components and systems presents ongoing challenges for quality control and regulatory compliance. Siemens Healthineers must ensure consistent quality across suppliers and manufacturing facilities while managing complex logistics for sensitive medical equipment.

Competition and Market Pressure: Siemens Healthineers operates in a highly competitive medical technology market, facing pressure from other major medical device manufacturers and emerging technology companies. This competitive environment requires continuous innovation and quality improvement to maintain market position.

Current Status: Despite these recalls and challenges, Siemens Healthineers continues to operate as a leading global medical technology company. The company's prompt response to safety issues and commitment to quality improvement demonstrate its dedication to patient safety and product reliability in the healthcare sector.